KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Treasury Shares (2016 - 2026)

Neogenomics filings provide 16 years of Treasury Shares readings, the most recent being $3.7 million for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 7.62% to $3.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.7 million, a 7.62% increase, with the full-year FY2025 number at $552208.0, down 74.48% from a year prior.
  • Treasury Shares hit $3.7 million in Q1 2026 for Neogenomics, up from $552208.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.7 million in Q1 2026 to a low of $305105.0 in Q3 2023.
  • Median Treasury Shares over the past 5 years was $2.1 million (2023), compared with a mean of $2.0 million.
  • Biggest five-year swings in Treasury Shares: crashed 84.71% in 2023 and later skyrocketed 366.55% in 2025.
  • Neogenomics' Treasury Shares stood at $2.0 million in 2022, then dropped by 1.65% to $2.0 million in 2023, then grew by 10.3% to $2.2 million in 2024, then plummeted by 74.48% to $552208.0 in 2025, then skyrocketed by 575.1% to $3.7 million in 2026.
  • The last three reported values for Treasury Shares were $3.7 million (Q1 2026), $552208.0 (Q4 2025), and $3.0 million (Q3 2025) per Business Quant data.